全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

The Rising Trend of Metastatic Colorectal Cancer: A Hospital-Based Study across Age Groups

DOI: 10.4236/ojepi.2026.162017, PP. 231-237

Keywords: Metastatic Colorectal Cancer, Age Groups, Epidemiology, Screening, National Inpatient Sample, Temporal Trend

Full-Text   Cite this paper   Add to My Lib

Abstract:

Purpose: Metastatic colorectal cancer (mCRC) is a major contributor to cancer-related morbidity and mortality in the United States. Although colorectal cancer has traditionally affected older adults, emerging data suggest shifts in age-specific disease patterns. The purpose of this study was to evaluate age-stratified proportion of hospitalizations and temporal trends in hospitalizations for metastatic colorectal cancer using a nationally representative inpatient database to identify populations potentially underserved by current screening guidelines. Methods: A retrospective analysis of the National Inpatient Sample (NIS) from 2016 to 2019 was conducted. Hospitalizations with a diagnosis of mCRC were identified using ICD-10 codes. Patients were categorized into five age groups: ≤45, 46 - 55, 56 - 65, 66 - 75, 76 - 85, and ≥86 years. Descriptive statistics summarized proportion of hospitalizations, analysis of variance compared annual differences, and linear regression assessed temporal trends. Statistical significance was defined as p < 0.05. Results: A total of 426,025 hospitalizations were identified. Patients aged 66 - 75 years accounted for 73,070 cases and demonstrated a significant increase in proportion of hospitalizations from 24.62% in 2016 to 26.54% in 2019 (p < 0.05). Individuals aged ≤45 years and ≥76 years comprised approximately 29% of hospitalizations. Conclusion: Hospitalizations for metastatic colorectal cancer are increasing among adults aged 66 - 75 years, with a substantial burden also observed at age extremes. These findings suggest potential gaps in current screening strategies. These findings highlight age-specific disparities in hospitalization burden that may inform future screening and health system planning.

References

[1]  Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
[2]  Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48.
https://doi.org/10.3322/caac.21763
[3]  Willauer, A.N., Liu, Y., Pereira, A.A.L., Lam, M., Morris, J.S., Raghav, K.P.S., et al. (2019) Clinical and Molecular Characterization of Early-Onset Colorectal Cancer. Cancer, 125, 2002-2010.
https://doi.org/10.1002/cncr.31994
[4]  Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., et al. (Eds) (2021) SEER Cancer Statistics Review (CSR) 1975-2018. National Cancer Institute.
https://seer.cancer.gov/archive/csr/1975_2018/index.html
[5]  Wolf, A.M.D., Fontham, E.T.H., Church, T.R., Flowers, C.R., Guerra, C.E., LaMonte, S.J., et al. (2018) Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 68, 250-281.
https://doi.org/10.3322/caac.21457
[6]  Davidson, K.W., Barry, M.J., Mangione, C.M., Cabana, M., Caughey, A.B., Davis, E.M., et al. (2021) Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. JAMA, 325, 1965-1977.
https://doi.org/10.1001/jama.2021.6238
[7]  Kowalkowski, H., Austin, G., Guo, Y., Miller-Wilson, L. and DaCosta Byfield, S. (2023) Patterns of Colorectal Cancer Screening and Adherence Rates among an Average-Risk Population Enrolled in a National Health Insurance Provider during 2009-2018 in the United States. Preventive Medicine Reports, 36, Article ID: 102497.
https://doi.org/10.1016/j.pmedr.2023.102497
[8]  Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., et al. (2016) Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients with Stage II Colon Cancer. Science Translational Medicine, 8, 346ra92.
https://doi.org/10.1126/scitranslmed.aaf6219
[9]  Cohen, J.D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., et al. (2018) Detection and Localization of Surgically Resectable Cancers with a Multi-Analyte Blood Test. Science, 359, 926-930.
https://doi.org/10.1126/science.aar3247
[10]  Henriksen, T.V., Tarazona, N., Reinert, T., Roda, D., Pedersen, C.B., Rømer, M.U., et al. (2022) Serial Circulating Tumor DNA Analysis to Assess Recurrence Risk in Colorectal Cancer. JAMA Oncology, 8, 1-10.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133